Very early researchStudy completedNCT04049474What this trial is testingBronchoscopic Cryo-Immunotherapy of Lung CancerWho this might be right forAdvanced Non-small Cell Lung Cancer NYU Langone Health 21
Large-scale testing (Phase 3)Looking for participantsNCT07185997What this trial is testingStudy to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsWho this might be right forNon-Small-Cell Lung CancerMetastatic Non-Small-Cell Lung CancerAdvanced Non-Small-Cell Lung Cancer+3 more ArriVent BioPharma, Inc.
Testing effectiveness (Phase 2)UnknownNCT06231680What this trial is testingThalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)Who this might be right forLung Cancer, Nonsmall CellEsophageal Carcinoma Henan Cancer Hospital 132
Testing effectiveness (Phase 2)Study completedNCT01807546What this trial is testingOral Rigosertib for Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell CarcinomaAnal Squamous Cell CarcinomaLung Squamous Cell Carcinoma+4 more Traws Pharma, Inc. 64
Not applicableUnknownNCT03651986What this trial is testingDiagnostic and Monitoring Significance of ctDNA Methylation Analysis by NGS in Benign and Malignant Pulmonary NodulesWho this might be right forPulmonary Nodules AnchorDx Medical Co., Ltd. 10,560
Early research (Phase 1)Active Not RecruitingNCT05068102What this trial is testingTest How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking EzabenlimabWho this might be right forCarcinoma, Squamous Cell of Head and Neck (HNSCC)MelanomaNon-small Cell Lung Cancer (NSCLC) Boehringer Ingelheim 14
Testing effectiveness (Phase 2)Study completedNCT00002972What this trial is testingPaclitaxel in Treating Patients With Lung CancerWho this might be right forLung Cancer European Organisation for Research and Treatment of Cancer - EORTC 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06237881What this trial is testingKSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid TumorsWho this might be right forAdvanced Solid TumorMelanomaLung Neoplasms+1 more M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT02417701What this trial is testingSapanisertib in Treating Patients With Stage IV or Recurrent Lung CancerWho this might be right forRecurrent Lung Squamous Cell CarcinomaStage IV Lung Squamous Cell Carcinoma AJCC v7 National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT05226728What this trial is testingPharmacokinetically-guided on the Individualization of Pembrolizumab Administration in the Treatment of Lung CancerWho this might be right forNon-small Cell Lung Cancer Sun Yat-sen University 33
Not applicableUnknownNCT04489992What this trial is testingExperiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare SystemWho this might be right forAI (Artificial Intelligence)Mammary CancerLung Cancer+6 more Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department 133,000
Not applicableStudy completedNCT01309087What this trial is testingAirway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS CLIAWho this might be right forLung Cancer Allegro Diagnostics, Corp. 756
Testing effectiveness (Phase 2)Study completedNCT01725165What this trial is testingSurgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung CancerWho this might be right forRecurrent Lung Non-Small Cell CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7 M.D. Anderson Cancer Center 85
Large-scale testing (Phase 3)Active Not RecruitingNCT06396065What this trial is testingPhase III Study of AK112 for NSCLC PatientsWho this might be right forNon-Squamous Non-small Cell Lung Cancer Summit Therapeutics 420
Testing effectiveness (Phase 2)Ended earlyNCT00549328What this trial is testingMonotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung CancerWho this might be right forLung Cancer, Non-Small Cell GlaxoSmithKline 14
Not applicableLooking for participantsNCT02682667What this trial is testingBiospecimen Procurement for Center for Immuno-Oncology Immunotherapy ProtocolsWho this might be right forMultiple MyelomaLymphoma, Non-HodgkinLeukemia-Lymphoma, Adult T-Cell+2 more National Cancer Institute (NCI) 500
Testing effectiveness (Phase 2)Looking for participantsNCT06363734What this trial is testingOsimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II TrialWho this might be right forNon-small Cell Lung CancerEGFR Activating MutationCell Cycle Deregulation+1 more Tianjin Medical University Cancer Institute and Hospital 32
Testing effectiveness (Phase 2)UnknownNCT04524299What this trial is testingStudy of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLCWho this might be right forNon-small Cell Lung Cancer Sun Yat-sen University 160
Not applicableWithdrawnNCT01300299What this trial is testingSTEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO)Who this might be right forNon-small Cell Lung Cancer (NSCLC) University of Louisville
Testing effectiveness (Phase 2)Study completedNCT00092001What this trial is testingStudy Of SU011248 In Patients With Metastatic Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Pfizer 111